Patent Yard Sign in
Canadian application, no grantCanada

Conjugated anti-psychotic drugs and uses thereof

CA 2461663 A1 · Owner: Rephaeli, Ada · Inventors: Weizman, Abraham; Nudelman, Abraham; Rephaeli, Ada

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel chemical conjugates of anti-psychotic drugs and organic acids uses , thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents and their syntheses are disclosed. , The organic acids are selected to reduce side effects induced by the antipsychotic drugs and/or to exert an anti-proliferative activity.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 29, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 29, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 29, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 29, 2002
GrantedNo grant recorded
Term endedSeptember 29, 2022
Patent numberCA 2461663 A1
Classification (IPC)A61K31/54 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedSep 29, 2002Term endedSep 29, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.